These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7244362)

  • 1. Antipyrine metabolites in two populations.
    Inaba T; Uchino H; Kadar D; Kalow W
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):235-44. PubMed ID: 7244362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipyrine metabolism in the Venda.
    Sommers DK; Moncrieff J; Avenant JC
    Hum Toxicol; 1987 Mar; 6(2):127-31. PubMed ID: 3557469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacoanthropology: drug metabolism.
    Kalow W
    Fed Proc; 1984 May; 43(8):2326-31. PubMed ID: 6714441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated high-performance liqiud chromatographic method for the determination of antipyrine and its metabolites in urine. Some preliminary results obtained from smokers and non-smokers.
    Nakagawa A; Nakamura K; Ishizaki T; Chiba K
    J Chromatogr; 1982 Sep; 231(2):349-60. PubMed ID: 7130315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human metabolism of antipyrine labelled with 14C in the pyrazolone ring or in the N-methyl group.
    Uchino H; Inaba T; Kalow W
    Xenobiotica; 1983 Mar; 13(3):155-62. PubMed ID: 6613161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cigarette smoke on antipyrine metabolite formation in rats.
    Nakagawa A; Chiba K; Ishizaki T; Nakamura K
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis.
    Teunissen MW; Spoelstra P; Koch CW; Weeda B; van Duyn W; Janssens AR; Breimer DD
    Br J Clin Pharmacol; 1984 Nov; 18(5):707-15. PubMed ID: 6508980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic method for the determination of the three main oxidative and 3-carboxylic antipyrine metabolites in human urine.
    Palette C; Cordonnier P; Naline E; Advenier C; Pays M
    J Chromatogr; 1991 Jan; 563(1):103-13. PubMed ID: 2061375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination studies of antipyrine and its metabolites in healthy Saudi Arabians.
    Ali HA; el-Yazigi A; Sieck JO; Døssing M; Saour J; Raines DA; Ernst P
    Hum Exp Toxicol; 1994 Oct; 13(10):658-62. PubMed ID: 7826682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.
    Posner J; Danhof M; Teunissen MW; Breimer DD; Whiteman PD
    Br J Clin Pharmacol; 1987 Jul; 24(1):51-5. PubMed ID: 3620285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of sex and oral contraceptive steroids on antipyrine metabolite formation.
    Teunissen MW; Srivastava AK; Breimer DD
    Clin Pharmacol Ther; 1982 Aug; 32(2):240-6. PubMed ID: 7094512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
    Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
    Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.
    Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD
    Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
    Danhof M; Krom DP; Breimer DD
    Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly sensitive and specific gas chromatographic-tandem mass spectrometric method for the determination of trace amounts of antipyrine metabolites in biological material.
    Engel G; Hofmann U; Eichelbaum M
    J Chromatogr B Biomed Appl; 1995 Apr; 666(1):111-6. PubMed ID: 7655608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of enzyme induction on antipyrine metabolite formation.
    Danhof M; Verbeek RM; van Boxtel CJ; Boeijinga JK; Breimer DD
    Br J Clin Pharmacol; 1982 Mar; 13(3):379-86. PubMed ID: 7059438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.
    Buchanan N; Davis M; Danhof M; Breimer DD
    Br J Clin Pharmacol; 1980 Oct; 10(4):363-8. PubMed ID: 7448107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipyrine metabolism in man: simultaneous determination of norantipyrine and 4-hydroxyantipyrine in urine by gas chromatography.
    Inaba T; Fischer NE
    Can J Physiol Pharmacol; 1980 Jan; 58(1):17-21. PubMed ID: 7378903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
    St Peter JV; Abul-Hajj Y; Awni WM
    Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.